Forty young companies will pitch to potential investors and others throughout the course of the Nov. 7-8 Wisconsin Early Stage Symposium at Madison’s Monona Terrace Convention Center. That includes 24 companies selected by conference organizers to present Nov. 7 during the Tech Council Investor Networks tracks and 16 more picked for the fast-moving Elevator Pitch […]
– Demand accelerated from healthcare providers as more than 11,000 ordered their initial Cologuard test during the third quarter, and nearly 132,000 have ordered since the test was launched – Gross margin increased 320 basis points to 75 percent – Exact Sciences now has in-network contracts with all five top commercial health plans, increasing patient […]
Stratatech is starting a test of its StrataGraft skin tissue to see how well it works on children who have suffered serious burns. It’s the first time the Madison company — a subsidiary of British-based Mallinckrodt Pharmaceuticals — will study the use of its engineered skin tissue on pediatric burn patients; up to now, only […]
Xconomy Wisconsin — Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors, according to a regulatory filing. Twenty-three investors participated in the equity funding round, according to the filing, which was made public earlier this week. Founded in 2011, Invenra has […]
UW-Madison’s Forward BIO Institute has been awarded $5 million from the National Institutes of Health for tissue manufacturing. The grant was announced yesterday at the Biohealth Summit by Professor Bill Murphy, the institute’s director. “This is a unique public-private collaboration that’s committed to advancing the global biomanufacturing industry,” he said. “We want to train the […]
The recently announced Forward BIOLABS will serve as a landing place for startups, many of which will come out of UW-Madison research. That’s according to co-founder Jessica Martin Eckerly. She says the nonprofit’s goal is to establish a fully equipped life sciences laboratory for early-stage companies, making it easier for them to bring their ideas […]
Arrowhead Pharmaceuticals says it has reached a licensing and collaboration agreement with Janssen Pharmaceuticals that will bring the company $250 million to start and ultimately could be worth as much as $3.7 billion. Janssen will get the worldwide exclusive license for ARO-HBV, a drug that treats chronic hepatitis B, and an option to collaborate with […]
An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health. The test began in August, according to a statement last week by the National Institute of Allergy and Infectious Diseases. Fifty healthy children between […]
Discovery to Product, which supports and mentors faculty, staff and student innovators and entrepreneurs on campus, is offering a new program called Innovation to Market. The fall I2M program builds on the success of D2P’s Igniter program cohorts that helped start 19 companies over the past three years. “The goals of D2P, located within the […]
A new study from NeuroPointDX of Madison and University of California researchers shows biochemical markers could allow for earlier identification of autism spectrum disorder. Lead author David Amaral says this discovery could also lead to avenues for therapeutic intervention. NeuroPointDX is a division of Stemina Biomarker Discovery, also based in Madison, and Amaral is from […]
